A global network of stem cell cores that includes ISCRM’s Tom and Sue Ellison Stem Cell Core has received a 2026 Public Service Award from the International Society for Stem Cell Research (ISSCR). Read More
ISCRM researchers have shown that an AI-designed signaling protein (known as a ligand) can be used to mature ameloblasts capable of secreting more mineralized enamel, representing another important step forward for regenerative dentistry. Read More
An interdisciplinary team of ISCRM researchers has received an $8.6 million grant from the NIH to accelerate cell therapies for diabetes by achieving more reliable and reproducible generation of fully functional pancreatic islets from multiple stem cell lines. Read More
Research from Julie Mathieu and Carol Ware adds to understanding of human early development and the clinical utility of late naïve hESC derived directly from blastocysts. Read More
Julie Mathieu, PhD and Niclas Bengtsson, PhD have received prestigious awards from the John H. Tietze Foundation Trust that will help fuel promising research underway in their labs. Read More
Thelma Escobar, PhD is collaborating with the Doulatov Lab and the Stem Cell Core to study how mutations in the gene NPM1 drive AML onset. Read More
Fueled in part by a New Investigator Award from the Cancer Consortium, ISCRM faculty member Julie Mathieu, PhD is partnering with scientists at the Institute for Protein Design and Fred Hutch to develop new treatments for renal cell carcinoma. Read More
Researchers from the Ruohola-Baker Lab have collaborated with the Institute for Protein Design on a technology in which designed proteins assemble antibodies in nanocage structures, increasing their potency against cancer, COVID-19, and other diseases. Read More
February 7, 2019 Of all the mysteries surrounding the beginning of human life, one question has drawn particular interest from researchers at the Institute for Stem Cell and Regenerative Medicine […] Read More